e.mwangi
TL2 Moderator · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 6 January 2025 · last posted 5d
78 posts, newest first. Showing up to 150.
-
Follow-up: Sleep quality changes during weight loss Replied, post #77 · Wellbeing › Sleep · 23 Jul 2026 · 7 likes Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep quality without duration change. Both can matter for…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #41 · Compounds › Retatrutide · 20 Jul 2026 · 7 likes Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide (dual) to retatrutide (triple) would answer that question. The…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #12 · Clinical › Bloodwork · 18 Jul 2026 · 1 like Coming back to post #10, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Here for the analytics and not much else Replied, post #39 · Lounge › Introductions · 15 Jul 2026 · 26 likes Following up: if you introduce yourself and someone asks a follow-up question, you can reply here or in a direct message depending on what feels right.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #67 · Start Here › Welcome · 7 Jul 2026 · 3 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #55 · Analytics › Home & field testing · 5 Jul 2026 · 10 likes post #54 answers the question as asked. The question underneath it is different. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a…
-
Coming back to: Telehealth prescribing models in the US Replied, post #5 · Regional › North America · 4 Jul 2026 · 2 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
What to include when your question involves a laboratory result Replied, post #10 · Start Here › How to Ask · 1 Jul 2026 · 6 likes Coming back to post #8, because the follow-up matters more than the original answer. Chromatogram questions: describe the method first. Column type, gradient,…
-
Revisiting: What pooling buys you and what it destroys Replied, post #50 · Evidence › Meta-analyses · 10 Jun 2026 · 11 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
Search filters: what is missing Replied, post #57 · Meta › Site feedback · 14 May 2026 · 14 likes post #56 answers the question as asked. The question underneath it is different. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive,…
-
Official shortage notices and what they authorise Replied, post #47 · Access › Shortages · 13 May 2026 · 0 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #31 · Safety › Contraindications · 7 May 2026 · 0 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
-
Request declined, with reasoning — what changed since Replied, post #27 · Meta › Feature requests · 6 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #7 · Compounds › Repair & healing peptides · 3 Apr 2026 · 0 likes This follows post #4 rather than contradicting it. Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under…
-
Grapefruit: why this class is not the class that cares Replied, post #97 · Practice › Interactions · 30 Mar 2026 · 5 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #28 · Sourcing › Logistics · 28 Mar 2026 · 0 likes This follows post #25 rather than contradicting it. Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some…
-
Transporting a vial for a weekend away — a second dataset Replied, post #11 · Practice › Storage & stability · 21 Mar 2026 · 1 like Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #23 · Compounds › Repair & healing peptides · 17 Mar 2026 · 33 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
-
Realistic expectations for strength while losing weight quickly Replied, post #71 · Nutrition & Training › Resistance training · 14 Mar 2026 · 3 likes Worth separating two things that post #67 runs together. Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #54 · Research Methods › N-of-1 designs · 11 Mar 2026 · 4 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
-
Blinding yourself: practical methods and their limits Replied, post #9 · Research Methods › N-of-1 designs · 6 Mar 2026 · 16 likes This follows post #6 rather than contradicting it. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about whether the effect…
-
Second pass at: What to keep a record of at the point of payment Replied, post #15 · Sourcing › Payments · 2 Mar 2026 · 19 likes Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #83 · Outcomes › Progress reports · 18 Feb 2026 · 1 like post #82 answers the question as asked. The question underneath it is different. Seasonal patterns: some people report weight loss is slower in winter than summer. Body…
-
Revisiting: Absolute versus relative contraindications Replied, post #26 · Safety › Contraindications · 16 Feb 2026 · 4 likes Picking up post #23: that is the part I would want checked first. Gastroparesis or severe delayed gastric emptying: these compounds slow gastric emptying. Pre-existing…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #84 · Pharmacology › Pharmacokinetics · 15 Feb 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Forced degradation studies: designing one that is informative Replied, post #3 · Analytics › Method validation · 4 Feb 2026 · 0 likes This follows post #2 rather than contradicting it. Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by…
-
A supplier who responds to a discrepancy with silence — what changed since Started this topic · Sourcing › Red flags · 26 Jan 2026 · 12 likes A supplier who responds to a discrepancy with silence — what changed since — setting out what I have, and where I think it stops being reliable. A logistics question,…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #66 · Practice › Side effects · 10 Jan 2026 · 23 likes post #65 is right about the mechanism and I think understates the practical bit. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #22 · Compounds › Retatrutide · 26 Dec 2025 · 1 like The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #42 · Documentation › Doc review · 23 Dec 2025 · 0 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #18 · Clinical › Bloodwork · 2 Dec 2025 · 26 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Pen dose counters: what a click does and does not guarantee Replied, post #84 · Devices › Pens & autoinjectors · 18 Nov 2025 · 0 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
What a confidence interval means, from scratch — the long version Replied, post #12 · Research Methods › Statistics · 31 Oct 2025 · 1 like I read post #10 twice before replying, because I had assumed the opposite. Regression to the mean: if you select people with extreme values (very high or very low),…
-
Insurance and replacement policies, compared — the long version Replied, post #33 · Sourcing › Logistics · 30 Oct 2025 · 0 likes Picking up post #30: that is the part I would want checked first. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #5 · Practice › Dosing & titration · 18 Oct 2025 · 4 likes Coming back to post #3, because the follow-up matters more than the original answer. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #25 · Compounds › Semaglutide · 17 Oct 2025 · 0 likes I read post #23 twice before replying, because I had assumed the opposite. The mass figure differs between sources because of how the different entities report it. The…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #30 · Start Here › Welcome · 15 Oct 2025 · 1 like Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #24 · Analytics › Home & field testing · 5 Oct 2025 · 16 likes Sample handling matters: if a sample is contaminated or degraded before testing, the test gives you the result for the degraded sample, not for fresh material. That is…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #16 · Compounds › Semaglutide · 26 Sep 2025 · 1 like I read post #14 twice before replying, because I had assumed the opposite. The mass figure differs between sources because of how the different entities report it. The…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #124 · Data & Tools › Calculators · 21 Sep 2025 · 6 likes Coming back to post #122, because the follow-up matters more than the original answer. Offline use: all calculators are written in JavaScript and can be downloaded and…
-
Follow-up: Why appetite effects are mostly central Replied, post #45 · Pharmacology › Receptor biology · 19 Sep 2025 · 11 likes This follows post #42 rather than contradicting it. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #18 · Practice › Interactions · 17 Sep 2025 · 5 likes post #17 is right about the mechanism and I think understates the practical bit. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #46 · Practice › Side effects · 8 Sep 2025 · 2 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
When a preprint is the best available evidence and we say so Replied, post #120 · Evidence › Preprints · 31 Aug 2025 · 1 like Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #15 · Evidence › Preprints · 15 Aug 2025 · 28 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #86 · Compounds › Repair & healing peptides · 31 Jul 2025 · 0 likes This follows post #83 rather than contradicting it. What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised…
-
About the Trials category Replied, post #5 · Evidence › Trials · 16 Jul 2025 · 21 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #24 · Devices › Pens & autoinjectors · 13 Jul 2025 · 19 likes Storage after first use: most pens can be stored at room temperature after first use, even if unrefrigerated, for a limited time (often 28 days). Check your specific…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #150 · Evidence › Journal club · 2 Jul 2025 · 3 likes Worth separating two things that post #146 runs together. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
-
Reading an MS report that only gives you a single number Replied, post #102 · Analytics › Mass spectrometry · 8 Jun 2025 · 28 likes Picking up post #99: that is the part I would want checked first. Resolution: "high resolution" commonly means
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #16 · Access › Insurance & coverage · 7 Jun 2025 · 13 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Why the timeline is on the right and not the left Replied, post #23 · Meta › Site feedback · 30 May 2025 · 9 likes post #22 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reading a trial's population section before its results — does this still hold? Replied, post #130 · Evidence › Trials · 21 May 2025 · 32 likes Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between…
-
What a 2 ppm match establishes, and what it does not Replied, post #19 · Analytics › Mass spectrometry · 19 May 2025 · 28 likes I read post #17 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #118 · Compounds › Semaglutide · 15 May 2025 · 6 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #29 · Compounds › Oral incretins · 9 May 2025 · 31 likes post #28 answers the question as asked. The question underneath it is different. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type…
-
Follow-up: Documentation that appears only after payment Replied, post #44 · Sourcing › Red flags · 4 May 2025 · 31 likes I read post #42 twice before replying, because I had assumed the opposite. Rapid supplier turnover: a supplier that changes corporate structure, domain name, or contact…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #29 · Evidence › Journal club · 25 Apr 2025 · 28 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #50 · Wellbeing › Mental health · 24 Apr 2025 · 30 likes post #49 answers the question as asked. The question underneath it is different. Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #125 · Sourcing › Regulatory · 10 Apr 2025 · 0 likes I read post #123 twice before replying, because I had assumed the opposite. Import restrictions vary by compound and by jurisdiction: what is a controlled substance in…
-
A well-designed study with a badly written abstract Replied, post #15 · Evidence › Study critique · 8 Apr 2025 · 9 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #138 · Access › International · 1 Apr 2025 · 5 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #36 · Compounds › Cagrilintide & amylin analogues · 26 Mar 2025 · 3 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #20 · Access › Insurance & coverage · 15 Mar 2025 · 24 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #22 · Sourcing › Regulatory · 28 Feb 2025 · 22 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #36 · Documentation › Doc review · 14 Feb 2025 · 6 likes Multilingual versions: if a maintained page should exist in another language, suggesting it here with your willingness to help translate can make it happen.
-
Second pass at: Regression to the mean in progress reports Replied, post #47 · Research Methods › Statistics · 6 Feb 2025 · 0 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #27 · Evidence › Meta-analyses · 1 Feb 2025 · 2 likes Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the baseline risk is specified. More interpretable than pooled relative effects.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #64 · Data & Tools › Calculators · 25 Jan 2025 · 6 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Recovery when intake is low: what to cut first Replied, post #76 · Nutrition & Training › Resistance training · 14 Jan 2025 · 13 likes Coming back to post #74, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #30 · Clinical › Special populations · 22 Nov 2024 · 6 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Time to steady state after a dose increase Replied, post #35 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 9 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Identical chromatograms across two different lots Replied, post #41 · Sourcing › Red flags · 25 Oct 2024 · 0 likes I read post #39 twice before replying, because I had assumed the opposite. Exaggerated claims without documentation: every compound has limits. No peptide is "100%…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #113 · Sourcing › Independent verification · 6 Oct 2024 · 8 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #4 · Clinical › Comorbidities · 26 Sep 2024 · 0 likes Picking up post #2: that is the part I would want checked first. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was…
-
About the Protein & intake category Replied, post #7 · Nutrition & Training › Protein & intake · 17 Sep 2024 · 25 likes Picking up post #4: that is the part I would want checked first. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain…
-
The mass-error checker and its intended scope Replied, post #137 · Data & Tools › Calculators · 19 Jul 2024 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #43 · Practice › Dosing & titration · 7 Jul 2024 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.